|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00438672 |
|
Date of registration:
|
20/02/2007 |
|
Primary sponsor: |
|
|
Public title:
|
Corticosteroid Injection for Common Upper Extremity Problems
|
|
Scientific title:
|
Corticosteroid Injection for Common Upper Extremity Problems |
|
Date of first enrolment:
|
April 2003 |
|
Target sample size:
|
64 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00438672 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
David Ring, MD, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Massachusetts General Hospital |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Age 18 to 64 years
- onset of pain within the past 6 months
- willing to try a steroid injection in the elbow
Exclusion Criteria:
- systemic inflammatory diseases (e.g., rheumatoid arthritis)
- pregnancy
- prior steroid injection, iontophoresis treatments with corticosteroids, or surgery
for their pain
- history of adverse reaction to lidocaine
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Lateral Elbow Pain
|
|
Intervention(s)
|
|
Drug: Placebo Injection
|
|
Drug: Steroid (dexamethasone) Injection
|
|
Primary Outcome(s)
|
|
Disabilities of the Arm, Shoulder, and Hand (DASH) Questionnaire
[Time Frame: 6 months]
|
|
Visual Analog Scale for Pain
[Time Frame: 6 months]
|
|
Secondary ID(s)
|
|
2003-P-000322
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|